Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Capstone Therapeutics Corp. (CAPS : NSDQ)

• Company Description    Capstone Holding Corp. primary business activities presently include the operations of TotalStone LLC, a construction materials company. Capstone Holding Corp. is headquartered in Alsip, Illinois. Number of Employees: 38

• Price / Volume Information    Yesterday's Closing Price: $1.51 Daily Weekly Monthly 20 Day Moving Average: 75,004 shares Shares Outstanding: 0.16 (millions) Market Capitalization: $0.24 (millions) Beta: -0.82 52 Week High: $15.10 52 Week Low: $1.40 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -20.53% -24.83% 12 Week -37.56% -47.62% Year To Date -32.59% -36.86%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5141 W. 122nd Street - Alsip,IL 60803 USA ph: 708-371-0660 fax: 602-286-5300 investors@capstoneholdingcorp.com http://www.capstonethx.com

• General Corporate Information    Officers Matthew E.Lipman - Chief Executive Officer Michael Toporek - Chairman Edward Schultz - Chief Financial Officer John M.Holliman - Director Gordon Strout - Director Peer Information Capstone Therapeutics Corp. (CSRLY) Capstone Therapeutics Corp. (ARRD) Capstone Therapeutics Corp. (CGMCQ) Capstone Therapeutics Corp. (CMCJY) Capstone Therapeutics Corp. (OMRP) Capstone Therapeutics Corp. (ABLT) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: BLDG&CONST-MISC Sector: Construction CUSIP: 14068E208 SIC: 5030 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/21/25 Share - Related Items Shares Outstanding: 0.16 Most Recent Split Date: 9.00 (0.00:1) Beta: -0.82 Market Capitalization: $0.24 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/21/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.01 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -12.76% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - 1.14 12/31/24 - 1.02 Quick Ratio 06/30/25 - - 03/31/25 - 0.47 12/31/24 - 0.25 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -4.73 Book Value 06/30/25 - - 03/31/25 - 171.13 12/31/24 - -19.40 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - 7.33 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.28 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - 21.85 12/31/24 - -

Powered by Zacks Investment Research ©